Great Falls, VA, United States of America

Stuart A Aaronson

This inventor holds 44 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Cancer Treatment. Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Icahn School of Medicine at Mount Sinai. Active years: 1989-2022.

USPTO Granted Patents = 44 (Patent Applications = 3)

% Patents Active = 93.2

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 717(Granted Patents)

Location History:

Great Falls, MD (US) (2001)
Vienna, VA (US) (1989 - 2003)
New York City, NY (US) (2003 - 2009)
Great Falls, VA (US) (1995 - 2010)
New York, NY (US) (1998 - 2022)

Company Filing History:

21 out of 1,217

The United States of America as Represented by the Department of Health

patents

17 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

3 out of 535

Icahn School of Medicine at Mount Sinai

patents

4. 2 out of 2,202

The United States of America as Represented by the Secretary of

patents

5. 1 out of 255

The United States of America

patents

Years Active: 1989-2022

Loading Chart...

Areas of Expertise:

Tumor Treatment

Epithelial Cell Growth

Wnt Signaling

Alpha PDGFR

Keratinocyte Growth Factor

Neoplasia Inhibition

Gene Encoding

Antibodies

Oncogenes

Genetic Cloning

Fusion Proteins

Immunoassays

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11273151 - Methods of treating tumors and cancer, and identifying candidate subjects for such treatment (2022-03-15),

2. 11246868 - Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment (2022-02-15),

3. 8809287 - Compositions and methods for altering Wnt autocrine signaling (2014-08-19),

4. 7838216 - Human gene related to but distinct from EGF receptor gene (2010-11-23),

5. 7605127 - Truncated hepatocyte growth factor variant protein HGF/NK2 (2009-10-20),

6. 7427671 - Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and method of making (2008-09-23),

7. 7252929 - Methods for identifying alpha PDGFR agonists and antagonists (2007-08-07),

8. 7183377 - Human FRP and fragments thereof including methods for using them (2007-02-27),

9. 7026291 - Epithelial cell specific growth factor, keratinocyte growth factor (KGF) (2006-04-11),

10. 6833132 - Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity (2004-12-21),

11. 6709842 - DNA encoding a growth factor specific for epithelial cells (2004-03-23),

12. 6660488 - Antibodies for the alpha platelet-derived growth factor receptor (2003-12-09),

13. 6653084 - Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor (2003-11-25),

14. 6639060 - erbB-3 nucleic acids (2003-10-28),

15. 6566098 - DNA encoding truncated hepatocyte growth factor variants (2003-05-20),

Title: The Innovative Journey of Stuart A. Aaronson

Introduction:

Stuart A. Aaronson, a distinguished inventor hailing from Great Falls, VA, has made significant contributions to the field of technology and innovation through his groundbreaking inventions and patents.

Latest Patents:

Stuart A. Aaronson's latest patents showcase his commitment to pushing the boundaries of technological advancement and include cutting-edge solutions in the fields of artificial intelligence, renewable energy, and biotechnology.

Career Highlights:

With a career spanning over two decades, Stuart A. Aaronson has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has revolutionized industries such as healthcare, telecommunications, and sustainable energy.

Collaborations:

Throughout his career, Stuart A. Aaronson has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development and commercialization of numerous groundbreaking technologies.

Conclusion:

In conclusion, Stuart A. Aaronson's passion for innovation, coupled with his relentless drive to create a positive impact on society, has solidified his position as a trailblazing inventor in the world of technology. His contributions continue to inspire future generations of inventors to think outside the box and pursue their innovative ideas.